John Simes

John Simes

UNVERIFIED PROFILE

Are you John Simes?   Register this Author

Register author
John Simes

John Simes

Publications by authors named "John Simes"

Are you John Simes?   Register this Author

100Publications

3135Reads

32Profile Views

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial.

J Clin Neurosci 2019 Dec 30;70:157-163. Epub 2019 Sep 30.

Prince of Wales Clinical School, Cure Brain Cancer Biomarkers and Translational Research Group, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2019.08.044DOI Listing
December 2019

Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".

Circulation 2019 02;139(9):1245-1246

Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Australia (A.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038480DOI Listing
February 2019

Anti-angiogenic therapy for high-grade glioma.

Cochrane Database Syst Rev 2018 11 22;11:CD008218. Epub 2018 Nov 22.

Medical Oncology, Alfred Hospital, Commercial Road, Melbourne, Victoria, Australia, 3004.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD008218.pub4
Publisher Site
http://dx.doi.org/10.1002/14651858.CD008218.pub4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516839PMC
November 2018

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.

Lancet 2018 10 4;392(10155):1311-1320. Epub 2018 Oct 4.

Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)31652-0DOI Listing
October 2018

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis.

Ther Adv Med Oncol 2018 6;10:1758835918788500. Epub 2018 Aug 6.

NHMRC Clinical Trials Centre, Australia New Zealand Gynaecological Oncology Group, University of Sydney, Camperdown, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918788500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080081PMC
August 2018

Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change.

Asia Pac J Clin Oncol 2018 Feb 26;14(1):74-83. Epub 2017 Sep 26.

Sydney Catalyst Translational Cancer Research Centre, University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ajco.12765
Publisher Site
http://dx.doi.org/10.1111/ajco.12765DOI Listing
February 2018

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.

Pharmacoeconomics 2018 01;36(1):67-78

Sydney Medical School, NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-017-0565-6DOI Listing
January 2018

Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis.

Am J Obstet Gynecol 2018 01 30;218(1):1-18. Epub 2017 Oct 30.

National Health and Medical Research Council Clinical Trials Center, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2017.10.231DOI Listing
January 2018

When do patient reported quality of life indicators become prognostic in breast cancer?

Health Qual Life Outcomes 2018 Jan 12;16(1):13. Epub 2018 Jan 12.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Locked Bag 7, Camperdown, NSW, 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-017-0834-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767023PMC
January 2018

Persistent psychological distress and mortality in patients with stable coronary artery disease.

Heart 2017 12 26;103(23):1860-1866. Epub 2017 Jun 26.

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-311097DOI Listing
December 2017

Delayed versus Immediate Cord Clamping in Preterm Infants.

N Engl J Med 2017 12 29;377(25):2445-2455. Epub 2017 Oct 29.

From the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (W.T.-M., A. Kirby, K.R., L.A., R.B., S.F., V.G., A. Ghadge, W.H., A. Keech, L. Sebastian, J.S.), University of Sydney (J.M., N.E., M.F., D.I., M.J., M.K., H. Popat, H.L., D.O.), Royal North Shore Hospital (Y.C.), and University of New South Wales (K.L.), Sydney, Australian National University, Canberra (M.A.-L., G.R.), University of Queensland, Brisbane (P.C., H.L., M. Pritchard), James Cook University, Cairns (G.K.), University of Western Australia, Perth (A. Gill, J.N., K.S.), Flinders University, Adelaide (S.M.), Monash University (A.S., E.W.) and University of Melbourne (S.W.), Melbourne, Mercy Hospital for Women, Heidelberg (A.W.), and University of Newcastle, Newcastle (K.W., P.F.), and University of Wollongong, Wollongong (I.W.) - all in Australia; Baylor College of Medicine, Houston (K.A., M.B., M. Pammi); Aga Khan University Hospital, Karachi, Pakistan (S.A., L. Sheikh); Hôpital Antoine-Beclere, Clamart, France (D.L.); University of Nottingham, Nottingham, United Kingdom (L.D.); Dalhousie University, Halifax, NS, Canada (W.E.-N.); University of Auckland, Auckland (K.G.), and University of Otago, Dunedin (P.W., J.G., H. Patel) - both in New Zealand; University College London, London (N.M.), and Royal Jubilee Maternity Hospital, Belfast (D.S.) - both in the United Kingdom; and University of Vermont, Burlington (R.S., L.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1711281DOI Listing
December 2017

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.

Neurooncol Pract 2017 Sep 25;4(3):171-181. Epub 2017 May 25.

Prince of Wales Hospital, Barker Street, Randwick, Sydney, NSW 2031, Australia (E.J.H.); University of New South Wales, Sydney, NSW 2052, Australia (E.J.H.); Royal Melbourne Hospital, Grattan Street, Parkville 3050, Melbourne Victoria, Australia (K.M.F., M.A.R., P.P., C.G.); Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Grattan Street Parkville 3052, Victoria, Australia (K.M.F., M.A.R.); National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia (E.H.B., K.S., A.L., J.S.); Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australia (L.C.); Sir Charles Gairdner Hospital, Nedlands, Perth 6009, Western Australia (A.K.N.); Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia (H.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655481PMC
September 2017

Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.

Circulation 2016 Nov 18;134(21):1637-1650. Epub 2016 Oct 18.

From Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia (Z.H.A., P.A.M., C.K.B., N.A.M., G.W., P.J.N., B.A.K., P.J.M.); King Fahad Medical City, Riyadh, Saudi Arabia (Z.H.A.); Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, VIC, Australia (Z.H.A., M.J.M., P.J.M.); NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia (J.S., E.H.B.); School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia (A.M.T., S.Z.); Royal Prince Alfred Hospital, Sydney, NSW, Australia (D.R.S.); Hópital Bichat-Claude Bernard and Université Paris 7, Paris, France (M.M.); George Institute for Global Health, Sydney, NSW, Australia (B.N., N.R.P., S.Z., G.S.H., J.C., M.W.); University College London and National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, London, UK (B.W.); Department of Cardiology, Royal Perth Hospital/University of Western Australia, Perth, WA, Australia (G.S.H.); George Institute for Global Health, University of Oxford, Oxford, UK (M.W.); and Department of Epidemiology, Johns Hopkins University, Baltimore, MD (M.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.023233DOI Listing
November 2016

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

J Clin Oncol 2016 08 20;34(23):2728-35. Epub 2016 Jun 20.

Nick Pavlakis, Niall C. Tebbutt, Lara R. Lipton, John R. Zalcberg, John Simes, and David Goldstein, Australasian Gastro-Intestinal Trials Group; Nick Pavlakis, Royal North Shore Hospital, University of Sydney; Katrin M. Sjoquist, Andrew J. Martin, Eric Tsobanis, Sonia Yip, and John Simes, National Health and Medical Research Council Clinical Trials Centre, University of Sydney; Katrin M. Sjoquist, Cancer Care Centre, St George Hospital; Sonia Yip, Sydney Catalyst Translational Cancer Research Centre; Mark Wong, Westmead Hospital; David Goldstein, Prince of Wales Hospital, Sydney, New South Wales; Niall C. Tebbutt, Austin Health; Lara R. Lipton, Western Health; Andrew Strickland, Monash Medical Centre; John R. Zalcberg, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Yoon-Koo Kang, Asan Medical Center, University of Ulsan College of Medicine; Yung-Jue Bang, Seoul National University Hospital; Sun Young Rha, Yonsei University College of Medicine; Jeeyun Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine; Jae-Yong Cho, Gangnam Severance Cancer Hospital, Yonsei University College of Medicine, Seoul; Jin Won Kim, Seoul National University Bundang Hospital, Seongnam, South Korea; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec; Christopher J. O'Callaghan, National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario; and Margot J. Burnell, Saint John Regional Hospital, Saint John, New Brunswick, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019744PMC
August 2016

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

J Clin Oncol 2016 07 25;34(19):2258-64. Epub 2016 Apr 25.

Eva Segelov, St Vincent's Clinical School, University of New South Wales; Subotheni Thavaneswaran, Kristy P. Robledo, Val J. Gebski, Mustafa Khasraw, Kate Wilson, and John Simes, National Health and Medical Research Council Clinical Trials Centre (NHMRC), University of Sydney; Lorraine A. Chantrill, Macarthur Cancer Therapy Centre, Campbelltown Hospital and Kinghorn Cancer Centre; Nick Pavlakis and Mustafa Khasraw, Royal North Shore Hospital University of Sydney, Sydney; Paul M. Waring and Sebastian Lunke, Centre for Translational Pathology, University of Melbourne; Jayesh Desai, Royal Melbourne Hospital; Jayesh Desai and Michael Jefford, Peter MacCallum Cancer Centre; Andrew Haydon, Alfred Hospital; Jeremy D. Shapiro, Cabrini Hospital, Melbourne; Louise M. Nott, Royal Hobart Hospital, Hobart; Christos S. Karapetis, Flinders University and Flinders Medical Centre; Timothy J. Price, Queen Elizabeth Hospital and Lyell McEwin Hospital, Adelaide; Craig Underhill, Border Medical Oncology, Albury-Wodonga; Guy van Hazel, Sir Charles Gairdner Hospital, Perth, Australia; Elena Elez, Vall d'Hebron University Hospital, Barcelona, Spain; Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Naples, Italy; and Harpreet Wasan, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6843DOI Listing
July 2016

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.

Circulation 2016 May 25;133(19):1851-60. Epub 2016 Mar 25.

From National Health and Medical Research Council Clinical Trials Centre, University of Sydney, New South Wales, Australia (W.E.H., J.S., A.K., A.C.K., H.P.); Green Lane Cardiovascular Service, Auckland City Hospital, New Zealand (H.D.W., R.A.S.); Department of Cardiology, Royal Melbourne Hospital and University of Melbourne, Victoria, Australia (D.H.); Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia (P.J.N.); Greenslopes Hospital, Brisbane, Queensland, Australia (D.M.C.); Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (D.R.S.); University of Western Australia, Perth, Australia (P.L.T.); University of Queensland, Brisbane, Queensland, Australia (M.W.); Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia (P.P.G.); and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018580DOI Listing
May 2016

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Clin Cancer Res 2016 05;22(10):2435-44

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0414DOI Listing
May 2016

Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.

J Clin Oncol 2016 Mar 25;34(9):936-44. Epub 2016 Jan 25.

Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.62
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.4767
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4767DOI Listing
March 2016

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.

J Clin Neurosci 2015 Dec 13;22(12):1889-94. Epub 2015 Aug 13.

Department of Medical Oncology, Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3050, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09675868150031
Publisher Site
http://dx.doi.org/10.1016/j.jocn.2015.06.005DOI Listing
December 2015

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.

Neuro Oncol 2015 Nov 30;17(11):1504-13. Epub 2015 Jun 30.

Royal Melbourne Hospital, Parkville, Australia (K.M.F, P.M.P, M.A.R.), National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia (J.S., C.S.B.B., E.H.B, K.S., A.L.); Sir Charles Gairdner Hospital, Nedlands, Australia (A.K.N); School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia (A.K.N); Austin Health, Heidelberg, Australia (L.C., G.F.); Royal North Shore Hospital, St Leonards, Australia (H.W.); Prince of Wales Hospital, Randwick, Australia (E.J.H); University of New South Wales, Sydney, Australia (E.J.H); Monash Medical Centre, Clayton, Australia (R.F.); Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia (P.M.P., M.A.R., G.F.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/11/1504.
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648304PMC
November 2015

Taxane-containing regimens for metastatic breast cancer.

Cochrane Database Syst Rev 2015 Jun 10(6):CD003366. Epub 2015 Jun 10.

Research Translation Group, National Health and Medical Research Council, 16 Marcus Clarke Street, Canberra, ACT, Australia, 2601.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD003366.pub3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464903PMC
June 2015

Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.

Clin Cancer Res 2015 May;21(9):2029-37

The Kinghorn Cancer Centre, Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland. Department of Surgery, Bankstown Hospital, Sydney, New South Wales, Australia. South Western Sydney Clinical School, Faculty of Medicine, University of NSW, Liverpool, New South Wales, Australia. West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0426DOI Listing
May 2015

Identification of the sentinel lymph node in the SNAC-1 trial.

ANZ J Surg 2015 Jan 15;85(1-2):58-63. Epub 2014 Feb 15.

Department of Surgery, University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.12527DOI Listing
January 2015

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.

Circulation 2014 Sep 25;130(13):1062-71. Epub 2014 Aug 25.

From the National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia (J.S., A.C.K., R.M.); the Division of Internal and Cardiovascular Medicine and Stroke Unit, Department of Internal Medicine, University of Perugia, Perugia, Italy (C.B., G.A.); the Population Health Research Institute, McMaster University, Hamilton, ON, Canada (J.W.E.); the Department of Cardiothoracic and Vascular Sciences, University of Padua, Padua (P.P.); and the Department of Haematology, South Eastern Area Laboratory Services (SEALS), Prince of Wales Hospital, Sydney, Australia (T.A.B.).

View Article

Download full-text PDF

Source
http://circ.ahajournals.org/content/early/2014/08/12/CIRCULA
Web Search
http://circ.ahajournals.org/content/early/2014/08/12/CIRCULA
Web Search
https://my.americanheart.org/idc/groups/ahamah-public/@wcm/@
Web Search
http://circ.ahajournals.org/lookup/doi/10.1161/CIRCULATIONAH
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.008828DOI Listing
September 2014

Neuro-oncology practices in Australia: a Cooperative Group for Neuro-Oncology patterns of care study.

Asia Pac J Clin Oncol 2014 Jun 29;10(2):162-7. Epub 2013 May 29.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12079DOI Listing
June 2014

Semiparametric methods for multistate survival models in randomised trials.

Stat Med 2014 May 13;33(10):1621-45. Epub 2013 Dec 13.

NHMRC Clinical Trials Centre, University of Sydney, New South Wales 2006, Australia; The George Institute, University of Sydney, New South Wales 2050, Australia; Department of Statistics, Macquarie University, North Ryde, New South Wales 2109, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6060DOI Listing
May 2014

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Clin Cancer Res 2014 Feb 11;20(3):744-53. Epub 2013 Nov 11.

Authors' Affiliation: Flinders University, Flinders Centre for Innovation in Cancer; Department of Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0606DOI Listing
February 2014

Which lipid measurement should we monitor? An analysis of the LIPID study.

BMJ Open 2014 Feb 21;4(2):e003512. Epub 2014 Feb 21.

Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2013-003512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931993PMC
February 2014

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.

Arterioscler Thromb Vasc Biol 2013 Dec 3;33(12):2902-8. Epub 2013 Oct 3.

From the Lipoprotein and Atherosclerosis Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia (P.J.N.); NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia (E.H.B., J.S., M.F.); Department of Epidemiology & Preventative Medicine, Monash University, Melbourne, Australia (A.M.T.); Green Lane Cardiovascular Research Unit, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Department of Medicine, University of Queensland, Brisbane, Australia (D.M.C.); Department of General and Interventional Cardiology, University Heart Centre Hamburg, Hamburg, Germany (S.B.); and Royal Prince Alfred Hospital Department of Biochemistry, Sydney, Australia (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.113.302479DOI Listing
December 2013

A funding model for public-good clinical trials.

Med J Aust 2013 Jul;199(2):90-1

Melbourne Health, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja13.10381DOI Listing
July 2013

Aspirin for preventing venous thromboembolism.

N Engl J Med 2013 02;368(8):773

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1215492DOI Listing
February 2013

Strategies to accelerate recruitment to NHMRC multi-centre clinical trials.

J Paediatr Child Health 2013 Jan;49(1):E103-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpc.12061DOI Listing
January 2013

Low-dose aspirin for preventing recurrent venous thromboembolism.

N Engl J Med 2012 Nov 4;367(21):1979-87. Epub 2012 Nov 4.

Department of Haematology, South Eastern Area Laboratory Services (SEALS), Prince of Wales Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1210384DOI Listing
November 2012

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation.

BMC Med Res Methodol 2012 Feb 14;12:12. Epub 2012 Feb 14.

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2288-12-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313870PMC
February 2012

Linking the evidence: intermediate outcomes in medical test assessments.

Int J Technol Assess Health Care 2012 Jan 23;28(1):52-8. Epub 2012 Jan 23.

The University of Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462311000717DOI Listing
January 2012

Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy.

J Clin Neurosci 2011 Nov 2;18(11):1444-8. Epub 2011 Aug 2.

Department of Medical Oncology, Royal Melbourne Hospital, Grattan Street, Victoria 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2011.02.026DOI Listing
November 2011

Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.

Asia Pac J Clin Oncol 2011 Sep;7(3):276-80

Sydney Cancer Centre, Royal Prince Alfred Hospital, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01422.xDOI Listing
September 2011

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Lancet Oncol 2011 Jul 16;12(7):681-92. Epub 2011 Jun 16.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147020451170142
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(11)70142-5DOI Listing
July 2011

Landscape of cancer clinical trials in Australia: using trial registries to guide future research.

Med J Aust 2011 Apr;194(8):387-91

Centre for Medical Psychology and Evidence-based Decision-making, University of Sydney, Sydney, NSW.

View Article

Download full-text PDF

Source
April 2011

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

J Natl Cancer Inst 2010 Aug 14;102(16):1253-62. Epub 2010 Jul 14.

Sydney Cancer Centre, Gloucester House 6, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq245DOI Listing
August 2010